Posters

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30

Sunday, September 28

4:45 PM - 6:00 PM PT

2358 - Treatment Interruptions in NSCLC Radiotherapy: Impact on Outcomes in a Statewide Quality Collaborative
Speaker: Elaimy, Ameer, MD, PhD, BS - University of Michigan Health System, Ann Arbor, MI
4:45 PM - 6:00 PM PT

2359 - Evaluation of Cumulative Doses to Organs at Risk during Lung Reirradiation
Speaker: Fallahi, Navid, MD - VCU Medical Center North Hospital - Massey Cancer Center, Richmond, VA
4:45 PM - 6:00 PM PT

2360 - Combining SBRT with GM-CSF and Peg-IFNa to Induce Abscopal Effects in Previously Treated Patients with Stage IV Thymic Tumors: A Prospective Study
Speaker: Fan, Min, MD, PhD - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai
4:45 PM - 6:00 PM PT

2361 - Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer with Liver Metastases: A Multicenter Retrospective Evaluation of Survival Outcomes
Speaker: Fan, Xinyu - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
4:45 PM - 6:00 PM PT

2362 - Role of Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer Patients with Bone Metastases: A Multicenter Retrospective Analysis
Speaker: Fan, Xinyu - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
4:45 PM - 6:00 PM PT

2363 - Investigation of the 'New-PDL1' Delta Radiomic Signature for Identifying Chemo-Radiotherapy Patients Who May Benefit from Consolidation Immunotherapy
Speaker: Filippi, Andrea, MD - Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan, Lombardia
4:45 PM - 6:00 PM PT

2364 - Impact of Systematic Invasive Mediastinal Staging on Recurrence Rates Following SBRT for Early-Stage NSCLC
Speaker: Fisher, Rachel, MS - University of Arizona College of Medicine - Phoenix, Phoenix, AZ
4:45 PM - 6:00 PM PT

2365 - Real World Radiographic Response Rates and Pre-Operative Attrition in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Neoadjuvant Chemoimmunotherapy
Speaker: Friedes, Cole, MD - University of Pennsylvania, Philadelphia, PA
4:45 PM - 6:00 PM PT

2366 - Urinary Quality of Life Outcomes with Stereotactic Body Radiation Therapy Delivered Daily Compared to Every Other Day in Patients with Prostate Cancer
Speaker: Gadam, Ramesh, MD, MBBS - University of Kansas Medical Center, Kansas City, KS
4:45 PM - 6:00 PM PT

2367 - Nutrition-Related Hematological and Body Composition Biomarkers in Stage III Unresectable NSCLC Treated with Immunochemoradiotherapy: A Retrospective Cohort Study
Speaker: Gan, Xia, MBBS - Hunan Cancer Hospital, Changsha, Hunan
4:45 PM - 6:00 PM PT

2368 - Impact of Radiation Therapy on Malignant Rhabdoid Tumor of the Kidney
Speaker: Gannon, David, MD - Vanderbilt University Medical Center, Nashville, TN
4:45 PM - 6:00 PM PT

2369 - Sexual Toxicity after Chemoradiation for Anal Cancer among Men who have Sex with Men
Speaker: Gold, Beck, BS - George Washington University School of Medicine, Washington, DC